Member Info for oogleflugal

Renx, Vrci , Niox from the Harwood stable all with huge growth potential in USA. Eckoh, which I sold recently , is set to grow most of its business in USA. I needed the dosh for Vrci and some others I have been watching . So bound to get a bid now! Still a lot of companies complaining about delayed contracts and weighting in the second half. Becoming a bit of a broken record that excuse. Like directors selling due to demand from fund mangers. Lot of clichés being used in companies results.

It seems pretty much a given that all you can do with uk stocks is wait for a US takeover. Harwood boss reckons another 20 -30 Aim listed companies will be bought by Americans, especially as many of derive most of their revenue from America. First we sold off the means of production now we are selling of the means of revenue and income for the UK.

All too familiar story. ‘Strong pipeline of opportunity’ but shrinking revenue and another loss . Hard act to follow

20 percent improvement and to be continued. Nice

Have no problem with directors and employees being rewarded for hard work and success. You can’t just say we are capitulate or socialist. That doesn’t explain the mechanism for incentives and rewards. Beg have done a similar thing and decimated shareholder value in the process. Why should directors take no risk at all and take free shares. More responsible companies operate excise of options which sets a fair discount for share to be bought when certain targets are met, not just help themselves to the cash. There are many things that need looking at to promote investing. This sort of greed leaves a very sour taste.

What’s slightly baffling is all the trades from 6.8p are buys. That’s what I paid. Must be several different market makers operating.

Must say I thought I had missed the boat/train/jet plane on yesterdays update. Glad Sara Barrington seems to be steering this rather than Julian Baines. A very assured and respectful interview with absolute clarity and clear vision. The whole Med tech sector has underperformed in the last five years according to Panmure Liberum. Thats mainly because its largely under delivered surely. Taken a small position today after watching for about a year.

Panmure Liberum say Alzheimer clinical trial grant worth £1 million. Sticking with £1.50 price target

TU ‘middle of July’ as stated in AGM . Was July 18th last year. So anytime now

Solid update with yet more record revenue ‘as anticipated’. Delayed orders largely recovered. Cautiously optimistic with sensibly conservative outlook .Broker target unchanged at £1.65.

It’s a vey prestigious endorsement . Monument in which they still have a 25 percent is also up for a big grant for their schizophrenia drug next year. This is a a very exciting time to be in as it hails a new dawn in the whole neurology field which includes remapping the brain in some studies. Still going to be a while to make these companies truly commercially profitable . When it happens it will be very big deal imo.

£32.4 purchase of shares adds nearly 3 million to market cap. Should be interesting when volumes increase!

D. Definitely tempting us! TU imminent I think. Must be very leaky news

Late reported 180,000 purchase @ £1.24 at 8.01 this morning. The saga is far from done.

Can’t think of aother situation where and actual offer is made with an indicative price and the share price drops. They only have a months to get the funds, finish diligence or pull out. Can’t see they would do that. I can see shareholders not accepting on a seemingly low price. I can see a better offer materialising possibly. Bizarre.

Flurry of chunky trades going through. Love the way PI investors are kept out of the loop

Obviously a much lower offer than many expected, but an offer none the less. Looks like plenty of mileage in this yet. The big question is, is there anyone with interest yet to throw their hat in the ring whilst impartially observing proceedings. £1.35 is the first and opening bid, still well below placing price I believe. More than happy with that , although doesn’t seem to reflect potential value, but there has to be something in it for the takeover company too. Won’t be surprised if late party goers start arriving now, but not disappointed if they don’t.

As discussed by Paul Hill on Vox today, when they set out the strategic revue 8 months ago business has continued to grow exponentially, so any bids were doomed to keep pace with the rapid growth. It made impossible to do a deal without a knock out bid, and in this market nobody is going to be able to do that. They worked out a possible target of £2.00 if growth keeps pace with current rate. The volatility is simply down to people betting on a takeover or not and loosing sight of what they do, what they have achieved and the quality of the business. I’ve been here for well over a year, trading in and out like many. Now the dust is settling and no more constrains on what management can say. May continue to drift for a while, but I’m back in for the longer term again

Some major share shuffling going on still. I’ve followed the CFOs example and put some more shares in my ISA and not sold any in my nominee . Just the breakfast part of the bed and breakfast .

That’s A good question R. Something he seems able to do with amazing frequency. Either very canny or lucky. I don’t know whether he is one of those traders with banks of screens. It’s been pretty difficult to predict this stock. When they released an update it dropped about 20 percent when they confirmed the figures a few weeks later it jumped back up! Crazy. Holding firm around 42p but could be a while before we get figures in November unless their is some contract news in betweeen.